{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:23:29Z","timestamp":1770816209923,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.mcna.2025.04.004","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T15:38:47Z","timestamp":1748014727000},"page":"1241-1253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimal Diuretic Strategies for Chronic Heart Failure"],"prefix":"10.1016","volume":"109","author":[{"given":"Satoshi","family":"Shoji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Osorio","family":"Nader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2025.04.004_bib1","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.mcna.2025.04.004_bib2","first-page":"2129","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.mcna.2025.04.004_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion \u2014 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.mcna.2025.04.004_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ejhf.462","article-title":"Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction","volume":"18","author":"Damman","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.mcna.2025.04.004_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11897-024-00643-3","article-title":"Diuretic treatment in patients with heart failure: current evidence and future directions\u2014Part II: combination therapy","volume":"21","author":"Cuthbert","year":"2024","journal-title":"Curr Heart Fail Rep"},{"issue":"19","key":"10.1016\/j.mcna.2025.04.004_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194378","article-title":"Different impact of beta-blockers on long-term mortality in heart failure patients with and without chronic obstructive pulmonary disease","volume":"10","author":"Higuchi","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.mcna.2025.04.004_bib8","series-title":"Cochrane database of systematic reviews. Vol 4","article-title":"Diuretics for heart failure","author":"Faris","year":"2012"},{"issue":"2","key":"10.1016\/j.mcna.2025.04.004_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials","volume":"82","author":"Faris","year":"2002","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib10","article-title":"Diuretics for heart failure","volume":"2019","author":"Faris","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"10.1016\/j.mcna.2025.04.004_bib11","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2025.04.004_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2025.04.004_bib13","first-page":"1","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.mcna.2025.04.004_bib14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.mcna.2025.04.004_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2025.04.004_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ehjcvp\/pvx020","article-title":"Loop diuretics for chronic heart failure: a foe in disguise of a friend?","volume":"4","author":"Kapelios","year":"2018","journal-title":"Eur Hear J - Cardiovasc Pharmacother"},{"issue":"14","key":"10.1016\/j.mcna.2025.04.004_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2012.12.043","article-title":"Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?","volume":"61","author":"Bikdeli","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mcna.2025.04.004_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/eurheartj\/ehi890","article-title":"Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.mcna.2025.04.004_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2007.05.032","article-title":"A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure","volume":"125","author":"Ahmed","year":"2008","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2025.04.004_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.mcna.2025.04.004_bib21","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","article-title":"Relation of loop diuretic dose to mortality in advanced heart failure","volume":"97","author":"Eshaghian","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-5273(99)00129-1","article-title":"The prognostic implications of outpatient diuretic dose in heart failure","volume":"71","author":"Harjai","year":"1999","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.mcna.2025.04.004_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/ejhf.1796","article-title":"Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry","volume":"22","author":"Kapelios","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"Suppl M","key":"10.1016\/j.mcna.2025.04.004_bib24","doi-asserted-by":"crossref","first-page":"M25","DOI":"10.1093\/eurheartj\/suz220","article-title":"Renal function, electrolytes, and congestion monitoring in heart failure","volume":"21","author":"Rossignol","year":"2019","journal-title":"Eur Heart J Suppl"},{"issue":"25","key":"10.1016\/j.mcna.2025.04.004_bib25","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jacc.2010.07.030","article-title":"Management of chronic heart failure guided by individual N-terminal ProB-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Stud","volume":"56","author":"Eurlings","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.mcna.2025.04.004_bib26","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal ProB-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2025.04.004_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2009.02.095","article-title":"N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure. Results from the BATTLESCARRED (NT-proBNP-Assisted treatment to lessen serial cardiac readmissions and death) trial","volume":"55","author":"Lainchbury","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ahj.2009.06.018","article-title":"Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials","volume":"158","author":"Felker","year":"2009","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.mcna.2025.04.004_bib29","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2006.10.081","article-title":"Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. The STARS-BNP multicenter study","volume":"49","author":"Jourdain","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mcna.2025.04.004_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cardfail.2012.05.005","article-title":"Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized proBNP outpatient tailored chronic heart failure therapy (PROTECT) study","volume":"18","author":"Gaggin","year":"2012","journal-title":"J Card Fail"},{"issue":"22","key":"10.1016\/j.mcna.2025.04.004_bib31","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mcna.2025.04.004_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide\u2013guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA, J Am Med Assoc"},{"issue":"9766","key":"10.1016\/j.mcna.2025.04.004_bib33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"issue":"10304","key":"10.1016\/j.mcna.2025.04.004_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet"},{"issue":"10394","key":"10.1016\/j.mcna.2025.04.004_bib35","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","article-title":"Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial","volume":"401","author":"Brugts","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2025.04.004_bib36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10741-024-10426-6","article-title":"Non-invasive heart failure monitoring: leveraging smart scales and digital biomarkers to improve heart failure outcomes","volume":"29","author":"Wattanachayakul","year":"2024","journal-title":"Heart Fail Rev"},{"issue":"5","key":"10.1016\/j.mcna.2025.04.004_bib37","article-title":"Use of a cardiac scale to predict heart failure events: design of SCALE-HF 1","volume":"16","author":"Fudim","year":"2023","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.mcna.2025.04.004_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2017.02.120","article-title":"Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations","volume":"240","author":"Amir","year":"2017","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.mcna.2025.04.004_bib39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ejhf.3290","article-title":"Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: congest-HF","volume":"26","author":"Curtain","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.mcna.2025.04.004_bib40","article-title":"Impact of a novel wearable sensor on heart failure rehospitalization: an open-label concurrent-control clinical trial","volume":"12","author":"Boehmer","year":"2024","journal-title":"JACC Hear Fail"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ejhf.1402","article-title":"Reduced loop diuretic use in patients taking sacubitril\/valsartan compared with enalapril: the PARADIGM-HF trial","volume":"21","author":"Vardeny","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.mcna.2025.04.004_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ejhf.2703","article-title":"Sacubitril\/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial","volume":"25","author":"Chatur","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.mcna.2025.04.004_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.120.051783","article-title":"Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: the EMPEROR-reduced trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mcna.2025.04.004_bib44","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.120.047077","article-title":"Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF","volume":"142","author":"Jackson","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mcna.2025.04.004_bib45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamacardio.2023.1090","article-title":"Safety and efficacy of empagliflozin and diuretic use in patients with heart failure and preserved ejection fraction: a post hoc analysis of the EMPEROR-preserved trial","volume":"8","author":"Butler","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"31","key":"10.1016\/j.mcna.2025.04.004_bib46","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/eurheartj\/ehad283","article-title":"Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial","volume":"44","author":"Chatur","year":"2023","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.mcna.2025.04.004_bib47","article-title":"Reduced diuretic dose in patients treated with eplerenone: data from the EPHESUS trial","volume":"13","author":"Ferreira","year":"2020","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.mcna.2025.04.004_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2017.10.018","article-title":"Value of routine investigations to predict loop diuretic down-titration success in stable heart failure","volume":"250","author":"Martens","year":"2018","journal-title":"Int J Cardiol"},{"issue":"44","key":"10.1016\/j.mcna.2025.04.004_bib49","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1093\/eurheartj\/ehz554","article-title":"Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial","volume":"40","author":"Rohde","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.mcna.2025.04.004_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jchf.2021.01.013","article-title":"Pragmatic design of randomized clinical trials for heart failure: rationale and design of the TRANSFORM-HF trial","volume":"9","author":"Greene","year":"2021","journal-title":"JACC Hear Fail"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.1024","article-title":"Potential advantages of torsemide in patients with heart failure: more than just a \u2018water pill\u2019","volume":"20","author":"Greene","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ahj.2014.12.009","article-title":"A reappraisal of loop diuretic choice in heart failure patients","volume":"169","author":"Buggey","year":"2015","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.mcna.2025.04.004_bib53","article-title":"Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure","volume":"3","author":"Matsuo","year":"2016","journal-title":"Open Hear"},{"issue":"SUPPL. 1","key":"10.1016\/j.mcna.2025.04.004_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00005344-200110001-00017","article-title":"Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure","volume":"38","author":"Tsutsui","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"10.1016\/j.mcna.2025.04.004_bib55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"L\u00f3pez","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.mcna.2025.04.004_bib56","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"L\u00f3pez","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mcna.2025.04.004_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"Cos\u00edn","year":"2002","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.mcna.2025.04.004_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.mcna.2025.04.004_bib59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","article-title":"Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV - efficacy and quality of life","volume":"5","author":"M\u00fcller","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jep.13261","article-title":"Torasemide versus furosemide in treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Sherif","year":"2020","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"10.1016\/j.mcna.2025.04.004_bib61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial","volume":"329","author":"Mentz","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2025.04.004_bib62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.064842","article-title":"Effect of torsemide vs furosemide on symptoms and quality of life among patients hospitalized for heart failure: the TRANSFORM-HF randomized clinical trial","author":"Greene","year":"2023","journal-title":"Circulation"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:08:03Z","timestamp":1770804483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712525000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0025712525000616"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2025.04.004","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal Diuretic Strategies for Chronic Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2025.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}